Pemetrexed and Erlotinib for Metastatic Colorectal Cancer

NCT02723578 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: Pemetrexed
DRUG: Erlotinib

Sponsor

Yonsei University